Log in

NYSE:OMIOwens & Minor Stock Price, Forecast & News

$13.77
+1.02 (+8.00 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$12.90
Now: $13.77
$13.97
50-Day Range
$7.03
MA: $10.63
$17.01
52-Week Range
$3.63
Now: $13.77
$17.33
Volume2.63 million shs
Average Volume5.67 million shs
Market Capitalization$878.25 million
P/E RatioN/A
Dividend Yield0.08%
Beta0.59
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; various programs to provide logistics and marketing solutions to its suppliers; and contract logistics services to the pharmaceutical, biotechnology, and medical device industries offering a range of supply chain logistics services to manufacturers. In addition, it offers business services comprising order-to-cash, re-labeling, customer service, and returns management; and warehousing and transportation services consisting of storage, controlled-substance handling, cold-chain, emergency and export delivery, inventory management, and pick and pack services. The Global Products segment manufactures and sources medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
Read More
Owens & Minor logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 1.8Dividend Strength: 1.7Insider Behavior: 4.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.44 out of 5 stars


Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP69073210
Phone804-723-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.21 billion
Cash Flow$3.20 per share
Book Value$7.35 per share

Profitability

Net Income$-62,370,000.00

Miscellaneous

Employees15,400
Market Cap$878.25 million
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$13.77
+1.02 (+8.00 %)
(As of 08/10/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OMI News and Ratings via Email

Sign-up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Owens & Minor (NYSE:OMI) Frequently Asked Questions

How has Owens & Minor's stock been impacted by COVID-19 (Coronavirus)?

Owens & Minor's stock was trading at $4.48 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OMI stock has increased by 207.4% and is now trading at $13.77.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Owens & Minor?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Owens & Minor
.

When is Owens & Minor's next earnings date?

Owens & Minor is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Owens & Minor
.

How were Owens & Minor's earnings last quarter?

Owens & Minor, Inc. (NYSE:OMI) announced its quarterly earnings results on Tuesday, August, 4th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.19 by $0.01. The business earned $1.81 billion during the quarter, compared to analysts' expectations of $1.92 billion. Owens & Minor had a positive return on equity of 9.31% and a negative net margin of 1.23%. The company's revenue was down 23.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.10 earnings per share.
View Owens & Minor's earnings history
.

How often does Owens & Minor pay dividends? What is the dividend yield for Owens & Minor?

Owens & Minor announced a quarterly dividend on Tuesday, August 4th. Investors of record on Tuesday, September 15th will be given a dividend of $0.002 per share on Wednesday, September 30th. This represents a $0.01 dividend on an annualized basis and a dividend yield of 0.06%. The ex-dividend date is Monday, September 14th.
View Owens & Minor's dividend history
.

What guidance has Owens & Minor issued on next quarter's earnings?

Owens & Minor issued an update on its FY20 earnings guidance on Tuesday, August, 4th. The company provided EPS guidance of $1.00-1.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.06.

What price target have analysts set for OMI?

6 brokers have issued twelve-month price objectives for Owens & Minor's shares. Their forecasts range from $9.50 to $16.00. On average, they anticipate Owens & Minor's stock price to reach $12.25 in the next twelve months. This suggests that the stock has a possible downside of 11.0%.
View analysts' price targets for Owens & Minor
.

Has Owens & Minor been receiving favorable news coverage?

Media coverage about OMI stock has trended positive on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Owens & Minor earned a news sentiment score of 2.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days.
View the latest news about Owens & Minor
.

Who are some of Owens & Minor's key competitors?

What other stocks do shareholders of Owens & Minor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include Pfizer (PFE), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Enterprise Products Partners (EPD), Cisco Systems (CSCO), Micron Technology (MU), Alibaba Group (BABA), Gilead Sciences (GILD) and Applied Materials (AMAT).

Who are Owens & Minor's key executives?

Owens & Minor's management team includes the following people:
  • Mr. Charles C. Colpo, Sr. VP of Strategic Relationships (Age 61)
  • Mr. Edward A. Pesicka, Pres, CEO & Director (Age 51)
  • Mr. Robert K. Snead, Exec. VP & CFO (Age 42)
  • Mr. Michael Wayne Lowry, Sr. VP, Corp. Controller & Chief Accounting Officer (Age 57)
  • Mr. Joseph S. Pekala, Sr. VP & Chief Information Officer (Age 48)

What is Owens & Minor's stock symbol?

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Who are Owens & Minor's major shareholders?

Owens & Minor's stock is owned by a number of institutional and retail investors. Top institutional investors include LSV Asset Management (2.84%), Smith Graham & Co. Investment Advisors LP (1.79%), Principal Financial Group Inc. (0.83%), Russell Investments Group Ltd. (0.45%), Mackay Shields LLC (0.44%) and Cozad Asset Management Inc. (0.32%). Company insiders that own Owens & Minor stock include Charles C Colpo, Geoff Taylor Marlatt and Robert J Henkel.
View institutional ownership trends for Owens & Minor
.

Which major investors are selling Owens & Minor stock?

OMI stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., LSV Asset Management, UBS Group AG, New York State Common Retirement Fund, Texas Permanent School Fund, Honkamp Krueger Financial Services Inc., Arizona State Retirement System, and Cambria Investment Management L.P..
View insider buying and selling activity for Owens & Minor
.

Which major investors are buying Owens & Minor stock?

OMI stock was purchased by a variety of institutional investors in the last quarter, including Mackay Shields LLC, Hussman Strategic Advisors Inc., Exchange Traded Concepts LLC, Pacer Advisors Inc., Smith Graham & Co. Investment Advisors LP, Janney Montgomery Scott LLC, Alpha Windward LLC, and Hancock Whitney Corp.
View insider buying and selling activity for Owens & Minor
.

How do I buy shares of Owens & Minor?

Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Owens & Minor's stock price today?

One share of OMI stock can currently be purchased for approximately $13.77.

How big of a company is Owens & Minor?

Owens & Minor has a market capitalization of $878.25 million and generates $9.21 billion in revenue each year. The company earns $-62,370,000.00 in net income (profit) each year or $0.56 on an earnings per share basis. Owens & Minor employs 15,400 workers across the globe.

What is Owens & Minor's official website?

The official website for Owens & Minor is www.owens-minor.com.

How can I contact Owens & Minor?

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company can be reached via phone at 804-723-7000 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.